SecSonar.com

Quanterix Corporation (QTRX)

Quanterix Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Quanterix Corporation (QTRX) is a Medical - Devices company based in US with a market capitalization of $146.3M. Revenue grew 2.4% year-over-year and free cash flow was negative at -$79.8M. This page tracks QTRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 471 employees · IPO Dec 7, 2017

Valuation

Valuation & price

$2.75 · as of May 17, 2026 · -65.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.49

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.70$5.11$2.52Jul 25Dec 25Jul 26Jul 7, 25$6.30Jul 9, 25$5.90Jul 11, 25$5.89Jul 15, 25$5.49Jul 17, 25$5.51Jul 21, 25$5.18Jul 23, 25$5.69Jul 25, 25$5.85Jul 29, 25$6.08Jul 31, 25$5.94Aug 4, 25$6.04Aug 6, 25$5.61Aug 11, 25$4.58Aug 13, 25$4.79Aug 15, 25$4.57Aug 19, 25$5.03Aug 21, 25$4.84Aug 25, 25$4.67Aug 27, 25$4.61Aug 29, 25$4.55Sep 3, 25$4.35Sep 5, 25$4.55Sep 9, 25$4.29Sep 11, 25$4.79Sep 16, 25$5.28Sep 18, 25$5.58Sep 22, 25$5.45Sep 24, 25$5.30Sep 26, 25$5.19Sep 30, 25$5.43Oct 2, 25$5.65Oct 6, 25$5.88Oct 8, 25$6.00Oct 10, 25$5.64Oct 14, 25$5.86Oct 16, 25$5.95Oct 21, 25$6.06Oct 23, 25$5.86Oct 27, 25$5.68Oct 29, 25$5.17Oct 31, 25$5.34Nov 4, 25$5.21Nov 6, 25$4.99Nov 10, 25$5.12Nov 12, 25$5.22Nov 14, 25$5.74Nov 18, 25$5.62Nov 20, 25$5.91Nov 25, 25$7.23Nov 28, 25$7.26Dec 2, 25$6.89Dec 4, 25$7.70Dec 8, 25$7.55Dec 10, 25$7.62Dec 12, 25$7.56Dec 16, 25$7.36Dec 18, 25$6.80Dec 22, 25$6.80Dec 24, 25$6.62Dec 29, 25$6.36Jan 2, 26$6.43Jan 6, 26$6.55Jan 8, 26$6.51Jan 12, 26$7.36Jan 14, 26$7.35Jan 16, 26$7.40Jan 21, 26$7.05Jan 23, 26$6.48Jan 27, 26$6.66Jan 29, 26$6.69Feb 2, 26$6.50Feb 4, 26$6.32Feb 9, 26$6.17Feb 11, 26$5.98Feb 13, 26$5.74Feb 18, 26$5.80Feb 20, 26$5.76Feb 24, 26$5.70Feb 26, 26$6.72Mar 2, 26$6.33Mar 4, 26$5.86Mar 6, 26$5.06Mar 10, 26$5.02Mar 12, 26$4.76Mar 17, 26$4.72Mar 19, 26$4.41Mar 23, 26$3.94Mar 25, 26$3.96Mar 27, 26$3.58Mar 31, 26$3.52Apr 2, 26$3.79Apr 7, 26$3.54Apr 9, 26$3.30Apr 13, 26$3.39Apr 15, 26$3.60Apr 17, 26$3.50Apr 22, 26$3.26Apr 24, 26$3.28Apr 28, 26$3.34Apr 30, 26$3.13May 4, 26$3.37May 6, 26$3.29May 8, 26$2.83May 12, 26$2.91May 14, 26$2.77May 18, 26$2.52May 20, 26$2.52May 22, 26$2.69May 28, 26$3.05Jun 1, 26$3.50Jun 3, 26$3.53Jun 5, 26$3.30Jun 9, 26$3.09Jun 11, 26$3.03Jun 15, 26$3.10Jun 17, 26$2.88Jun 22, 26$3.49Jun 24, 26$3.78Jun 26, 26$4.32Jul 2, 26$4.28
$2.5152-week range$8.06
Loading valuation history…

Fundamentals

Key fundamentals

$146.3M

Market cap

2.4%

Revenue growth (YoY)

46.7%

Gross margin

-$79.8M

Free cash flow (USD)

-$81M

Net debt

Net cash position

11.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$17.6MFY 2017$22.9MFY 2018$37.6MFY 2019$56.7MFY 2020$86.4MFY 2021$110.6MFY 2022$105.5MFY 2023$121.1MFY 2024$135.4MFY 2025$138.7M
$17.6M$138.7M

Free cash flow by year

2016 → 2025

FY 2016$-18.3MFY 2017$-23.2MFY 2018$-30.2MFY 2019$-37.0MFY 2020$-27.3MFY 2021$-61.5MFY 2022$-60.0MFY 2023$-22.7MFY 2024$-38.5MFY 2025$-79.8M
-$18.3M-$79.8M

Gross margin by year

2021 → 2025

FY 202158.6%FY 202243.0%FY 202360.3%FY 202459.9%FY 202546.7%
58.6%46.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $10KMeadows Benjamin · Chief Commercial Officer · $9.7KJun 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 10, 2026Filing
  • 8-K eventCFO AppointmentJun 9, 2026Filing
  • 8-K eventCFO AppointmentMay 26, 2026Filing
  • 8-K eventCFO DepartureMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is Quanterix Corporation's market cap?

Quanterix Corporation (QTRX) has a market capitalization of $146.3M.

What is QTRX's P/E ratio?

A meaningful P/E ratio is not available for QTRX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is QTRX's price-to-book (P/B) ratio?

QTRX trades at 0.49 times book value per share.

Are insiders buying QTRX stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Quanterix Corporation in the last 90 days.

Same arena

Related companies in Medical - Devices

CVRX

CVRx, Inc.

$146.5M

SNWV

SANUWAVE Health, Inc.

$143.2M

QTI

QT Imaging Holdings, Inc.

$136.9M

MXCT

MaxCyte, Inc.

$135.5M

NNOX

Nano-X Imaging Ltd.

$134.7M

HYPR

Hyperfine, Inc.

$133.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.